Latest 
Recall of paracetamol 500mg tablets
M & A Pharmachem is recalling certain batches of paracetamol 500mg tablets because “a small number of pots” have been contaminated with fungus.
The recall was announced by the MHRA on Thursday June 13. The watchdog said that batches 0110 and 0174 had been found to contain tablets that were discoloured from the contamination, but said “it is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs”.
All wholesalers and healthcare professionals are advised to stop supplying from these tablets immediately, and to quarantine remaining stock and return it to the supplier.
Sponsored

Covid-19 and mental health
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.

Advising on EPs in a COVID era
With research suggesting a possible link between COVID-19 and EPs, make sure you’re confident discussing EPs and their treatment with customers
Record my learning outcomes